# Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

> **NCT01663285** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Urothelial Cancer
- Bladder Cancer

## Interventions

- **DRUG:** Neoadjuvant Cisplatin and Gemcitabine

## Key facts

- **NCT ID:** NCT01663285
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low study participant enrollment.
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01663285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01663285, "Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01663285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*